Interleukin-2-induced seborrhoeic dermatitis-like eruption.
Yamamoto
T
T
Tsuboi
R
R
D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D002292:Carcinoma, Renal Cell / Q000188:drug therapy; D012628:Dermatitis, Seborrheic / Q000139:chemically induced* / Q000175:diagnosis; D006801:Humans; D007376:Interleukin-2 / Q000009:adverse effects* / Q000627:therapeutic use; D007680:Kidney Neoplasms / Q000188:drug therapy; D008297:Male
D000970:Antineoplastic Agents; D007376:Interleukin-2